Department of Health and Human Services November 13, 2024 – Federal Register Recent Federal Regulation Documents
Results 1 - 12 of 12
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Produce Regulatory Program Standards
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Agency Information Collection Activities: Proposed Collection; Comment Request
This notice announces the intention of the Agency for Healthcare Research and Quality (AHRQ) to request that the Office of Management and Budget (OMB) approve an extension of the currently approved information collection project: "Medical Expenditures Panel SurveyInsurance Component."
Proposed Information Collection Activity; Objective Work Plan/On-Going Progress Report (Office of Management and Budget #0970-0452)
The Administration for Children and Families' (ACF) Administration for Native Americans (ANA) is requesting a 3-year extension to the Ongoing Progress Report (OPR) and the Objective Work Plan (OWP) (Office of Management and Budget #0970-0452, expiration September 30, 2026). Changes are proposed only to the report.
Public Workshop on Optimizing the Use of Real-World Evidence in Regulatory Decision-Making for Drugs and Biological Products-Looking Forward; Request for Comments
The Food and Drug Administration (FDA or Agency) is announcing a public workshop titled "Optimizing the Use of Real-World Evidence in Regulatory Decision-Making for Drugs and Biological ProductsLooking Forward." The purpose of the public workshop is to provide interested parties with an update on FDA's current activities related to real- world evidence (RWE) and to share accomplishments, ongoing challenges, and future opportunities. The public workshop will discuss potential next steps to promote the continued evolution and consistent application of real-world data (RWD) in drug development. This public workshop will be convened and supported by a cooperative agreement between FDA and the Duke University, Duke-Margolis Institute for Health Policy.
Determination That NUPLAZID (Pimavanserin Tartrate) Tablet, Equivalent 17 Milligram Base, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
The Food and Drug Administration (FDA or Agency) has determined that NUPLAZID (pimavanserin tartrate) tablet, equivalent (EQ) 17 milligram (mg) base, was not withdrawn from sale for reasons of safety or effectiveness. This determination will allow FDA to approve abbreviated new drug applications (ANDAs) for NUPLAZID (pimavanserin tartrate) tablet, EQ 17 mg base, if all other legal and regulatory requirements are met.
National Advisory Committee on Individuals With Disabilities and Disasters Public Meeting
The National Advisory Committee on Individuals with Disabilities and Disasters (NACIDD) announces it will conduct a public meeting. Notice of the meeting is required under section 10(a)(2) of the Federal Advisory Committee Act (FACA).
National Advisory Committee on Children and Disasters Public Meeting
The National Advisory Committee on Children and Disasters (NACCD or the Committee) will conduct a public meeting (virtual) to discuss potential recommendations to the HHS Secretary and ASPR regarding challenges, opportunities, and priorities for national public health and medical preparedness, response, and recovery specific to the needs of children and their families in disasters.
National Advisory Committee on Individuals With Disabilities and Disasters, National Advisory Committee on Seniors and Disasters, and the National Biodefense Science Board; Call for Member Nominees
ASPR, in HHS, is currently seeking applications from qualified individuals for memberships on the following national advisory committees (vacancies): The National Advisory Committee on Individuals with Disabilities and Disasters (NACIDD) (7 vacancies); the National Advisory Committee on Seniors and Disasters (NACSD) (7 vacancies); and the National Biodefense Science Board (NBSB) (7 vacancies). The HHS Secretary will appoint new voting members.
Charter Renewal for the Advisory Committee on Heritable Disorders in Newborns and Children
In accordance with the Federal Advisory Committee Act, the Department of Health and Human Services is hereby giving notice that the Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC) charter has been renewed.
Use of Federal Real Property To Assist the Homeless
The Department of Housing and Urban Development (HUD), the General Services Administration (GSA), and the Department of Health and Human Services (HHS) (the Agencies) administer the Title V program, which makes suitable Federal real properties categorized as underutilized, unutilized, excess, or surplus available to States, local government agencies, and 501(c)(3) tax-exempt non-profit organizations for use to assist the homeless. This final rule incorporates required statutory changes and current practices; updates references and terminology that are now outdated; and revises procedures for more efficient program administration in the Agencies' regulations.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
